Miljenko V. Pilepich

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

Miljenko V. Pilepich, Kathryn Winter, C.A. Lawton et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 911 citations

Urology, Androgen Suppression Adjuvant, Genitourinary Cancer +7

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

Miljenko V. Pilepich, Kathryn Winter, Madhu J. John et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 774 citations

Urology, Radiation Medicine, Radiation Therapy +7

Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

Mack Roach, Kyounghwa Bae, Joycelyn L. Speight et al. · Journal of Clinical Oncology · 2008 · 643 citations · Full text

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

Miljenko V. Pilepich, Richard Caplan, Roger W. Byhardt et al. · Journal of Clinical Oncology · 1997 · 609 citations

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

Miljenko V. Pilepich, William T. Sause, William U. Shipley et al. · Urology · 1995 · 489 citations

Urology, Radiation Medicine, Radiation Therapy +6